Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 06 - 11 crawled time : 16:20 save search
AbbVie Announces Late-Breaking Results from Phase 2 Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) at the European Hematology Association (EHA) Annual Congress
Published: 2022-06-11 (Crawled : 16:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
cd20 duobody trial results
Fiber Reinforced Composites (FRC) Market Size Worth USD 17.64 Billion, Globally, by 2028 at 6.7% CAGR - Industry Trends, Share, Value, Exclusive Analysis & Forecast Report by Zion Market Research
Published: 2022-06-11 (Crawled : 16:20) - prnewswire.com
FMC | $57.82 1.55% 0.0% 1.3M
|
Process Industries
| Email alert
Add to watchlist
research report market
Insights on Global GPON Equipment Market Size &Share Calculated to Reach USD 9.75 Billion by 2028, Exhibit a CAGR of 5.8% | Industry Trends, Value, Analysis & Forecast Report by ZMR
Published: 2022-06-11 (Crawled : 16:20) - prnewswire.com
ZTCOF | $1.91 -9.23% 200
|
Electronic Technology
| Email alert
Add to watchlist
ERIC | News | $5.1 0.79% 0.78% 19M
|
Electronic Technology
| Email alert
Add to watchlist
CSCO | $48.33 0.46% 0.46% 20M
|
Technology Services
| Email alert
Add to watchlist
report market
Demand for Global Medical Fluid Bags Market Size & Share | Exhibit a CAGR of 6.4% Growth | Industry Trends, Value, Analysis & Forecast Report by Zion Market Research
Published: 2022-06-11 (Crawled : 16:20) - prnewswire.com
TRUMY | $16.507 0.79% 34K
|
Manufacturing
| Email alert
Add to watchlist
TRUMF | $16.928 -17.59% 1.9K
|
Health Technology
| Email alert
Add to watchlist
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
| Email alert
Add to watchlist
research report growth market
Fiber Reinforced Composites (FRC) Market Size Worth USD 135.1 Billion, Globally, by 2028 at 6.2% CAGR - Industry Trends, Share, Value, Exclusive Analysis & Forecast Report by Zion Market Research
Published: 2022-06-11 (Crawled : 16:20) - prnewswire.com
AVNT | $42.52 0.38% -0.12% 620K
|
Process Industries
| Email alert
Add to watchlist
HXL | News | $61.71 0.51% 0.0% 1.1M
|
Electronic Technology
| Email alert
Add to watchlist
research report market
At 8.6% CAGR, Global Tissue Sealants and Tissue Adhesive Market Size & Share to Surpass USD 2.9 Billion by 2028 | Industry Trends, Growth, Value, Opportunities, Statistics, Analysis & Forecast Report by ZMR
Published: 2022-06-11 (Crawled : 16:20) - prnewswire.com
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
| Email alert
Add to watchlist
LUNA | News | $2.78 -0.71% -0.72% 1.1M
|
Electronic Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
report market
Genmab Announces Late-Breaking Phase 2 Trial Results of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Relapsed/Refractory Large B-cell Lymphoma (LBCL) Patients Presented at European Hematology Association (EHA) Presidential Symposium
Published: 2022-06-11 (Crawled : 16:20) - globenewswire.com
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
| Email alert
Add to watchlist
GNMSF | $290.38 3.83% 220
|
Health Technology
| Email alert
Add to watchlist
cd20 duobody symposium trial results
CRISPR Therapeutics Presents Positive Results from its Phase 1 COBALT™-LYM Trial of CTX130™ in Relapsed or Refractory T Cell Malignancies at the 2022 European Hematology Association (EHA) Congress
Published: 2022-06-11 (Crawled : 16:20) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M
|
Health Technology
| Email alert
Add to watchlist
ctx130 crispr trial therapeutics positive results phase 1
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.